MetastasisWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MegestrolAcetateImmunotherapyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearStagingMastodyniaEGFR(epidermalgrowth factorreceptor)Physicalactivity mayreduce therisk of breastcancersCyclophosphamideHerceptinPrecisionMedicineWomen ages40+ shouldhave a clinicalbreast examat least yearlyLumpFlowCytometryPaclitaxelGeneticPredispositionAbsoluteRiskOvarianSuppressionAdenocarcinomaCachexiaBrachytherapyDocetaxelDoxorubicinCytostaticNeoadjuvantTherapyTripleNegativeBreastCancerNeoplasmEstrogenAntiemeticCytotoxicAlopeciaMethotrexateGeneMutationGailModelDown-StagingHormoneReplacementTherapyCystChemotherapyIntraductalPapillomaMastectomyRadiotherapyFibroadenomaMRIMultimodalityTherapyGuaranteedRenewableInsuranceFISHKappaEpsilonMorpheaFamilyHistoryNodeNegativeCo-survivorRADPalpationTamoxifenInvasiveBreastCancerIn-situCarcinomaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDoseDenseTherapyCapecitabineRaloxifeneLymphoscintigraphyPARPInhibitorsOligometastases1 in 8womenBreastTomosynthesisBilateralProphylacticMastectomyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinibBRCAGeneCAMAdjuvantTherapyAnastrozoleACChemotherapy5-FluorouracilPI3KinaseInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAntibodyTherapyAdvocacyDimplingLymphNodeStatusLumpectomyAromataseInhibitorsPathologicResponseEstradiolTyrosine-KinaseInhibitormTORInhibitorsAngiogenesisDefinitiveSurgeryProgestinMultifocalTumorsBI-RADSGermlineMutationLCISHormoneReceptorStatusBevacizumabPalbociclibBOCAApoptosisKi-67RateExcisionalBiopsyER+CDK4/6InhibitorsHER-2TriplePositiveBreastCancerBiopsyCalcificationsRelapseChemopreventionPhyllodesTumorSERMAyurvedaCMFChemotherapySelf-examinationBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55For every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ER-PagetDiseaseCheckpointInhibitorBreastCancerGeneticCounselingAxillarySamplingGenomicTestingNodePositiveTumorGradeECOGScoreMetastasisWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.MegestrolAcetateImmunotherapyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearStagingMastodyniaEGFR(epidermalgrowth factorreceptor)Physicalactivity mayreduce therisk of breastcancersCyclophosphamideHerceptinPrecisionMedicineWomen ages40+ shouldhave a clinicalbreast examat least yearlyLumpFlowCytometryPaclitaxelGeneticPredispositionAbsoluteRiskOvarianSuppressionAdenocarcinomaCachexiaBrachytherapyDocetaxelDoxorubicinCytostaticNeoadjuvantTherapyTripleNegativeBreastCancerNeoplasmEstrogenAntiemeticCytotoxicAlopeciaMethotrexateGeneMutationGailModelDown-StagingHormoneReplacementTherapyCystChemotherapyIntraductalPapillomaMastectomyRadiotherapyFibroadenomaMRIMultimodalityTherapyGuaranteedRenewableInsuranceFISHKappaEpsilonMorpheaFamilyHistoryNodeNegativeCo-survivorRADPalpationTamoxifenInvasiveBreastCancerIn-situCarcinomaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDoseDenseTherapyCapecitabineRaloxifeneLymphoscintigraphyPARPInhibitorsOligometastases1 in 8womenBreastTomosynthesisBilateralProphylacticMastectomyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerLapatinibBRCAGeneCAMAdjuvantTherapyAnastrozoleACChemotherapy5-FluorouracilPI3KinaseInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAntibodyTherapyAdvocacyDimplingLymphNodeStatusLumpectomyAromataseInhibitorsPathologicResponseEstradiolTyrosine-KinaseInhibitormTORInhibitorsAngiogenesisDefinitiveSurgeryProgestinMultifocalTumorsBI-RADSGermlineMutationLCISHormoneReceptorStatusBevacizumabPalbociclibBOCAApoptosisKi-67RateExcisionalBiopsyER+CDK4/6InhibitorsHER-2TriplePositiveBreastCancerBiopsyCalcificationsRelapseChemopreventionPhyllodesTumorSERMAyurvedaCMFChemotherapySelf-examinationBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55For every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ER-PagetDiseaseCheckpointInhibitorBreastCancerGeneticCounselingAxillarySamplingGenomicTestingNodePositiveTumorGradeECOGScore

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Metastasis
  2. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  3. Megestrol Acetate
  4. Immunotherapy
  5. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  6. Staging
  7. Mastodynia
  8. EGFR (epidermal growth factor receptor)
  9. Physical activity may reduce the risk of breast cancers
  10. Cyclophosphamide
  11. Herceptin
  12. Precision Medicine
  13. Women ages 40+ should have a clinical breast exam at least yearly
  14. Lump
  15. Flow Cytometry
  16. Paclitaxel
  17. Genetic Predisposition
  18. Absolute Risk
  19. Ovarian Suppression
  20. Adenocarcinoma
  21. Cachexia
  22. Brachytherapy
  23. Docetaxel
  24. Doxorubicin
  25. Cytostatic
  26. Neoadjuvant Therapy
  27. Triple Negative Breast Cancer
  28. Neoplasm
  29. Estrogen
  30. Antiemetic
  31. Cytotoxic
  32. Alopecia
  33. Methotrexate
  34. Gene Mutation
  35. Gail Model
  36. Down-Staging
  37. Hormone Replacement Therapy
  38. Cyst
  39. Chemotherapy
  40. Intraductal Papilloma
  41. Mastectomy
  42. Radiotherapy
  43. Fibroadenoma
  44. MRI
  45. Multimodality Therapy
  46. Guaranteed Renewable Insurance
  47. FISH
  48. Kappa Epsilon
  49. Morphea
  50. Family History
  51. Node Negative
  52. Co-survivor
  53. RAD
  54. Palpation
  55. Tamoxifen
  56. Invasive Breast Cancer
  57. In-situ Carcinoma
  58. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  59. Dose Dense Therapy
  60. Capecitabine
  61. Raloxifene
  62. Lymphoscintigraphy
  63. PARP Inhibitors
  64. Oligometastases
  65. 1 in 8 women
  66. Breast Tomosynthesis
  67. Bilateral Prophylactic Mastectomy
  68. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  69. Lapatinib
  70. BRCA Gene
  71. CAM
  72. Adjuvant Therapy
  73. Anastrozole
  74. AC Chemotherapy
  75. 5-Fluorouracil
  76. PI3 Kinase Inhibitors
  77. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  78. Antibody Therapy
  79. Advocacy
  80. Dimpling
  81. Lymph Node Status
  82. Lumpectomy
  83. Aromatase Inhibitors
  84. Pathologic Response
  85. Estradiol
  86. Tyrosine-Kinase Inhibitor
  87. mTOR Inhibitors
  88. Angiogenesis
  89. Definitive Surgery
  90. Progestin
  91. Multifocal Tumors
  92. BI-RADS
  93. Germline Mutation
  94. LCIS
  95. Hormone Receptor Status
  96. Bevacizumab
  97. Palbociclib
  98. BOCA
  99. Apoptosis
  100. Ki-67 Rate
  101. Excisional Biopsy
  102. ER+
  103. CDK4/6 Inhibitors
  104. HER-2
  105. Triple Positive Breast Cancer
  106. Biopsy
  107. Calcifications
  108. Relapse
  109. Chemoprevention
  110. Phyllodes Tumor
  111. SERM
  112. Ayurveda
  113. CMF Chemotherapy
  114. Self-examination
  115. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  116. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  117. ER-
  118. Paget Disease
  119. Checkpoint Inhibitor
  120. Breast Cancer
  121. Genetic Counseling
  122. Axillary Sampling
  123. Genomic Testing
  124. Node Positive
  125. Tumor Grade
  126. ECOG Score